Search for astaxanthin and sleep and you will find confident claims backed by two Japanese trials. Both trials are real, both are randomized, and both are routinely described in a way that does not survive reading them.
The first found no effect on sleep. The second found an effect that the study’s own design cannot attribute to astaxanthin. Neither of those is a reason to dismiss the compound, but they are reasons to be precise about what has and has not been shown.
Key Takeaways
- In a 2020 trial, 25 adults took 12 mg/day of an astaxanthin-rich extract for eight weeks against 29 on placebo. There were no significant between-group differences in either stress or sleep [1].
- The reported sleep benefit came from a post-hoc subgroup: only participants scoring above 65 on the Depression-Dejection scale improved. Everyone else did not [1].
- A 2017 trial of 120 people found improved sleep onset latency, but the astaxanthin arm also contained zinc, and the zinc-only arm improved sleep efficiency and onset time on its own [2].
- No trial has tested astaxanthin alone against placebo for sleep as a pre-specified primary outcome in a general adult population.
- Pooled antioxidant data suggests doses below 20 mg/day produce no significant biomarker effect, and both sleep trials used 12 mg [3].
The 2020 trial, read carefully
Published in the Journal of Clinical Biochemistry and Nutrition, this study gave 25 adults aged 20 to 64 a supplement containing 12 mg of astaxanthin per day derived from Paracoccus carotinifaciens, and 29 adults a placebo, for eight weeks. Stress was measured with the Profile of Mood States, second edition. Sleep was measured with the Oguri-Shirakawa-Azumi Sleep Inventory for Middle-aged and Aged version [1].
The extract came from Paracoccus bacteria, not Haematococcus algae. Its astaxanthin is the free (unesterified) form, and 20 to 30% of the extract is adonirubin and adonixanthin, so these results should not be read across to Haematococcus products [5].
The result, stated plainly by the authors: no significant intergroup differences in stress or in sleep.
The investigators then divided participants by their Depression-Dejection score on the mood inventory, splitting at 65. In the group scoring above 65, sleep improved significantly with astaxanthin compared to placebo. In everyone else, and in stress measures across the board, nothing changed [1].
Why a subgroup finding is weaker than it sounds
Splitting data after the fact and testing the pieces is a known way to find effects that are not there. With a fixed number of participants, each subgroup is smaller and noisier than the whole, so the chance of a false positive rises. And every additional split is another opportunity for one of them to cross the significance threshold by chance.
Research note: A 12-week placebo-controlled trial in 120 healthy adults tested zinc-rich food and zinc-yeast plus astaxanthin oil on sleep [2].
That does not make the finding wrong. Post-hoc analysis is how real hypotheses get generated. It does mean the correct description of this trial is that it failed its main comparison and produced a hypothesis worth testing: that people with high depressive mood scores might see sleep benefits. As far as the published literature goes, nobody has run that follow-up.
The authors themselves phrased it as a possibility, writing that people who tend to be strongly depressed may experience improved sleep. Product pages tend to drop the hedge.
The 2017 trial has a different problem
This one, in Molecular Nutrition & Food Research, was larger and better designed in some ways: 120 healthy participants, 12 weeks, sleep recorded objectively by actigraphy rather than by questionnaire [2]. Actigraphy is a real improvement over self-report, because people are unreliable narrators of their own sleep.
The design used four arms: placebo, zinc-rich food, zinc- and astaxanthin-rich food, and placebo supplemented with zinc-enriched yeast plus astaxanthin oil.
Results: the zinc-rich food group fell asleep faster and had better sleep efficiency than placebo. The zinc yeast plus astaxanthin oil group significantly improved sleep onset latency [2].
Read the arms again. There is no astaxanthin-only arm. Zinc appears in every active condition. And the zinc-only condition worked. The study was explicitly built on the hypothesis that zinc induces non-REM sleep, with astaxanthin included because it can chelate minerals and might improve zinc absorption. Astaxanthin was the delivery hypothesis, not the active hypothesis.
You cannot separate an ingredient’s effect from a co-administered ingredient when no arm isolates it. This is the same structural problem covered in our article on combination supplement studies.
What about the mechanism argument?
The plausibility case for astaxanthin and sleep usually runs through oxidative stress and inflammation, both of which have genuine associations with poor sleep. Astaxanthin crosses the blood-brain barrier, which our article on astaxanthin and cognitive function covers in more detail, so the pathway is not fanciful.
Plausible mechanisms are cheap, though. The pooled human antioxidant data is itself equivocal: a systematic review and meta-analysis of nine randomized trials found the between-group antioxidant effect only borderline significant, and found significant effects on antioxidant capacity, isoprostane, and superoxide dismutase only at doses of 20 mg/day or higher. Below 20 mg, nothing reached significance [3].
The 2017 trial’s abstract does not report an astaxanthin dose, so how its dose compares with doses used elsewhere is unknown [2].
What would settle this
A trial with an astaxanthin-only arm, a pre-specified sleep primary outcome, objective measurement, at least 12 weeks, and a dose stated in advance (the EU authorises supplements up to 8 mg per day) [4]. Ideally recruiting people who actually sleep badly, since both existing trials enrolled general or healthy adults rather than a population with a sleep complaint, which leaves little room to improve.
None of that exists yet. Until it does, astaxanthin is not a sleep supplement with human evidence behind it. It is a supplement with one null trial containing a hypothesis-generating subgroup, and one trial where the plausible active ingredient was zinc.
Common questions
Does astaxanthin help you fall asleep faster?
The only trial reporting faster sleep onset gave participants zinc at the same time, and its zinc-only arm also improved onset time [2]. There is no evidence isolating astaxanthin for this.
Should I take astaxanthin at night?
There is no timing evidence for sleep because there is no established sleep effect to time. Astaxanthin is fat-soluble and absorption improves substantially when taken with dietary fat, which our articles on bioavailability and timing cover. Absorption, not bedtime, is the reason to pick a particular time.
Does it cause insomnia or vivid dreams?
Neither trial reported sleep disruption. The 2020 study specifically noted no safety problems on the parameters it tested [1]. Our side effects article covers the reported adverse event profile.
If I have low mood and poor sleep, is it worth trying?
That is precisely the subgroup where the 2020 trial found something, so it is the most defensible reason to try it, and it is still a post-hoc finding from 54 people that nobody has replicated [1]. It is a reasonable experiment, not an evidence-based recommendation, and persistent low mood with disrupted sleep is worth raising with a clinician regardless of what supplement is in the cupboard.
References
- Effect of astaxanthin-rich extract derived from Paracoccus carotinifaciens on the status of stress and sleep in adults. Journal of Clinical Biochemistry and Nutrition (2020). PMID 32231404
- Zinc-rich oysters as well as zinc-yeast- and astaxanthin-enriched food improved sleep efficiency and sleep onset in a randomized controlled trial of healthy individuals. Molecular Nutrition & Food Research (2017). PMID 28019085
- Effects of Astaxanthin Supplementation on Oxidative Stress. International Journal for Vitamin and Nutrition Research (2020). PMID 30982442
- European Food Safety Authority (EFSA NDA Panel) Safety of astaxanthin for its use as a novel food in food supplements. European Food Safety Authority (EFSA NDA Panel) (2020). source
- Masahiro Hayashi et al. Effect of astaxanthin-rich extract derived from Paracoccus carotinifaciens on cognitive function in middle-aged and older individuals. Journal of Clinical Biochemistry and Nutrition (2018). PMID 29610561
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
